# Efficacy and Safety Study of GED-0507-34-Levo for Treatment of UC

> **NCT02808390** · PHASE2 · TERMINATED · sponsor: **PPM Services S.A.** · enrollment: 19 (actual)

## Conditions studied

- Ulcerative Colitis

## Interventions

- **DRUG:** GED-0507-34-Levo 80 mg
- **DRUG:** GED-0507-34-Levo 160 mg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02808390
- **Lead sponsor:** PPM Services S.A.
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-11-28
- **Primary completion:** 2017-07-31
- **Final completion:** 2017-07-31
- **Target enrollment:** 19 (ACTUAL)
- **Why stopped:** Sponsor decision
- **Last updated:** 2018-11-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02808390

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02808390, "Efficacy and Safety Study of GED-0507-34-Levo for Treatment of UC". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02808390. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*